AI assistant
RESMED INC — Director's Dealing 2016
Apr 12, 2016
30071_dirs_2016-04-12_56ffc249-3ddc-4199-957a-cbd1b60a2237.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2016-04-04
Reporting Person: FARRELL PETER C (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-04-04 | ResMed Common Stock | M | 20000 | $25.54 | Acquired | 367978 | Direct |
| 2016-04-04 | ResMed Common Stock | S | 20000 | $58.62 | Disposed | 347978 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-04-04 | Resmed Stock Option Plan | $25.54 | M | 20000 | Disposed | 2016-12-17 | ResMed Common Stock (20000) | Direct |
Footnotes
F1: The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.
F2: Represents date options first became exercisable. Options vested 1/4 per year on the anniversary of the grant.
F3: This transaction was executed in multiple trades at prices ranging from 58.35 to 58.81. The price reported above represents the weighted average sales price. The reporting person will provide full information about the number of shares and prices at which the transaction was effected, on request, to the SEC staff, the issuer, or the security holder of the issuer.